Guenova, Emmanuella

The cGAS–STING pathway drives type I IFN immunopathology in COVID-19

Domizio, J. D., Gulen, M. F., Saidoune, F., Thacker, V. V., Yatim, A., Sharma, K., Nass, T., Guenova, E., Schaller, M., Conrad, C., et al. (2022) · Nature

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 538

The PROCLIPI international registry of early- stage mycosis fungoides identifies substantial diagnostic delay in most patients

Scarisbrick, J. J., Quaglino, P., Prince, H. M., Papadavid, E., Hodak, E., Bagot, M., Servitje, O., Berti, E., Ortiz‐Romero, P., Stadler, R., et al. (2019) · British Journal of Dermatology

Cutaneous lymphoproliferative disorders researchLymphoma Diagnosis and Treatment

Cited by 244

Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases

Seremet, T., Di Domizio, J., Girardin, A., Yatim, A., Jenelten, R., Messina, F., Saidoune, F., Schlapbach, C., Bogiatzi, S., Minisini, F., et al. (2024) · Nature Communications

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 57

Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion

Hodak, E., Geskin, L., Guenova, E., Ortiz-Romero, P. L., Willemze, R., Zheng, J., Cowan, R., Foss, F., Mangas, C., & Querfeld, C. (2023) · American Journal of Clinical Dermatology

Cutaneous lymphoproliferative disorders researchCancer and Skin Lesions

Cited by 47

LCK and HOMER1 gene expression-based classifier distinguishes early mycosis fungoides from eczema and psoriasis

Meinel, M., Langreder, N., Schmitt, A., Technau-Hafsi, K., Hillig, C., Roenneberg, S., Bernklauová, A., Říčař, J., Kacerovská, D., Wobser, M., et al. (2025) · medRxiv

Cutaneous lymphoproliferative disorders researchLymphoma Diagnosis and Treatment

Cited by 2